$2.35 Billion is the total value of Avidity Partners Management LP's 85 reported holdings in Q2 2024. The portfolio turnover from Q1 2024 to Q2 2024 was 45.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ISRG | Buy | INTUITIVE SURGICAL INC | $108,988,250 | +20.8% | 245,000 | +8.4% | 4.63% | +59.3% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $90,109,401 | -32.7% | 1,170,100 | -40.2% | 3.83% | -11.3% |
| NTRA | Sell | NATERA INC | $83,004,285 | +13.0% | 766,500 | -4.6% | 3.53% | +48.9% |
| ARVN | Buy | ARVINAS INC | $79,536,434 | -35.5% | 2,987,845 | +0.1% | 3.38% | -14.9% |
| ACHC | Buy | ACADIA HEALTHCARE COMPANY IN | $75,644,800 | -5.0% | 1,120,000 | +11.4% | 3.21% | +25.2% |
| Buy | DIANTHUS THERAPEUTICS INC | $75,497,938 | -7.4% | 2,917,231 | +7.3% | 3.21% | +22.0% | |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $68,467,550 | +19.2% | 3,335,000 | +38.2% | 2.91% | +57.2% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $67,595,970 | -8.6% | 491,000 | -8.5% | 2.87% | +20.4% |
| AVTR | Buy | AVANTOR INC | $65,423,200 | -5.1% | 3,086,000 | +14.5% | 2.78% | +25.1% |
| CI | THE CIGNA GROUP | $60,990,165 | -9.0% | 184,500 | 0.0% | 2.59% | +19.9% | |
| JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $58,114,485 | -17.4% | 544,500 | -6.8% | 2.47% | +8.9% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $53,946,000 | +48.5% | 222,000 | -8.6% | 2.29% | +95.7% |
| REGN | Sell | REGENERON PHARMACEUTICALS | $50,449,440 | -22.9% | 48,000 | -29.4% | 2.14% | +1.6% |
| ILMN | Buy | ILLUMINA INC | $49,893,640 | -21.7% | 478,000 | +3.0% | 2.12% | +3.2% |
| THC | Sell | TENET HEALTHCARE CORP | $49,487,160 | -21.7% | 372,000 | -38.1% | 2.10% | +3.2% |
| ABBV | Buy | ABBVIE INC | $47,648,256 | +15.3% | 277,800 | +22.4% | 2.02% | +51.9% |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $44,240,000 | +108.0% | 80,000 | +118.6% | 1.88% | +174.1% |
| Buy | STRUCTURE THERAPEUTICS INCsponsored ads | $42,215,250 | +14.0% | 1,075,000 | +24.4% | 1.79% | +50.3% | |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $41,279,740 | +2.2% | 383,000 | -10.1% | 1.75% | +34.6% |
| Sell | CG ONCOLOGY INC | $40,921,823 | -35.9% | 1,296,225 | -10.9% | 1.74% | -15.5% | |
| MRK | Sell | MERCK & CO INC | $40,235,000 | -39.3% | 325,000 | -35.3% | 1.71% | -19.9% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $39,456,000 | -9.5% | 960,000 | +2.8% | 1.68% | +19.4% |
| IDYA | Buy | IDEAYA BIOSCIENCES INC | $39,217,870 | +11.8% | 1,117,000 | +39.7% | 1.67% | +47.3% |
| DHR | Buy | DANAHER CORPORATION | $37,477,500 | +4.4% | 150,000 | +4.3% | 1.59% | +37.5% |
| JANX | Buy | JANUX THERAPEUTICS INC | $35,196,774 | +143.3% | 840,219 | +118.7% | 1.50% | +221.0% |
| UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $35,040,500 | -29.7% | 110,000 | -49.3% | 1.49% | -7.3% |
| INCY | New | INCYTE CORP | $32,067,980 | – | 529,000 | +100.0% | 1.36% | – |
| SGRY | Sell | SURGERY PARTNERS INC | $31,081,088 | -27.9% | 1,306,477 | -9.6% | 1.32% | -5.0% |
| New | PERSPECTIVE THERAPEUTICS INC | $30,285,550 | – | 3,037,668 | +100.0% | 1.29% | – | |
| AXSM | Sell | AXSOME THERAPEUTICS INC | $30,268,000 | -12.0% | 376,000 | -12.8% | 1.29% | +16.0% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $29,398,460 | -3.8% | 754,000 | +6.2% | 1.25% | +26.7% |
| DXCM | Buy | DEXCOM INC | $29,365,420 | +19.7% | 259,000 | +46.4% | 1.25% | +57.8% |
| RVMD | Buy | REVOLUTION MEDICINES INC | $29,301,550 | +43.2% | 755,000 | +18.9% | 1.24% | +88.6% |
| INSM | New | INSMED INC | $28,810,000 | – | 430,000 | +100.0% | 1.22% | – |
| ITCI | Sell | INTRA-CELLULAR THERAPIES INC | $27,396,000 | -34.0% | 400,000 | -33.3% | 1.16% | -13.1% |
| CGEM | New | CULLINAN THERAPEUTICS INC | $27,203,365 | – | 1,559,826 | +100.0% | 1.16% | – |
| GKOS | GLAUKOS CORP | $26,510,400 | +25.5% | 224,000 | 0.0% | 1.13% | +65.3% | |
| Buy | NEUROGENE INC | $26,475,071 | +11.8% | 727,537 | +56.4% | 1.12% | +47.3% | |
| ARGX | New | ARGENX SEsponsored adr | $26,017,420 | – | 60,500 | +100.0% | 1.11% | – |
| MIRM | Sell | MIRUM PHARMACEUTICALS INC | $24,996,446 | -12.9% | 731,104 | -36.0% | 1.06% | +14.7% |
| ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $24,128,640 | +110.7% | 531,000 | +136.0% | 1.02% | +177.8% |
| IMVT | Buy | IMMUNOVANT INC | $23,971,200 | +46.9% | 908,000 | +79.8% | 1.02% | +93.7% |
| RCKT | Buy | ROCKET PHARMACEUTICALS INC | $23,683,000 | -14.2% | 1,100,000 | +7.3% | 1.01% | +13.0% |
| LNTH | Sell | LANTHEUS HLDGS INC | $23,284,100 | -22.1% | 290,000 | -39.6% | 0.99% | +2.7% |
| PCVX | VAXCYTE INC | $21,444,840 | +10.5% | 284,000 | 0.0% | 0.91% | +45.5% | |
| Buy | APOGEE THERAPEUTICS INC | $19,163,450 | -25.1% | 487,000 | +26.5% | 0.81% | -1.3% | |
| Buy | JASPER THERAPEUTICS INC | $17,751,400 | -20.4% | 782,000 | +2.9% | 0.75% | +4.9% | |
| NEUMORA THERAPEUTICS INC. | $17,694,000 | -28.5% | 1,800,000 | 0.0% | 0.75% | -5.8% | ||
| LEGN | Sell | LEGEND BIOTECH CORPsponsored ads | $17,627,420 | -53.0% | 398,000 | -40.4% | 0.75% | -38.0% |
| GILD | New | GILEAD SCIENCES INC | $17,495,550 | – | 255,000 | +100.0% | 0.74% | – |
| PHAT | Sell | PHATHOM PHARMACEUTICALS INC | $16,686,000 | -9.4% | 1,620,000 | -6.6% | 0.71% | +19.4% |
| AZN | Buy | ASTRAZENECA PLCsponsored adr | $15,987,950 | +47.5% | 205,000 | +28.1% | 0.68% | +94.0% |
| KROS | Buy | KEROS THERAPEUTICS INC | $15,684,240 | +13.0% | 343,200 | +63.7% | 0.67% | +48.7% |
| Buy | BIOHAVEN LTD | $15,619,500 | +280.8% | 450,000 | +500.0% | 0.66% | +403.0% | |
| SNY | New | SANOFIsponsored adr | $15,283,800 | – | 315,000 | +100.0% | 0.65% | – |
| RGNX | REGENXBIO INC | $15,210,749 | -44.5% | 1,300,064 | 0.0% | 0.65% | -26.8% | |
| New | CONTEXT THERAPEUTICS INC | $14,875,807 | – | 7,419,355 | +100.0% | 0.63% | – | |
| EXAS | New | EXACT SCIENCES CORP | $14,301,625 | – | 338,500 | +100.0% | 0.61% | – |
| PRVA | PRIVIA HEALTH GROUP INC | $13,281,796 | -11.3% | 764,200 | 0.0% | 0.56% | +16.8% | |
| Buy | NEWAMSTERDAM PHARMA COMPANYordinary shares | $10,744,153 | -4.4% | 559,300 | +17.7% | 0.46% | +26.2% | |
| IMNM | IMMUNOME INC | $10,574,081 | -51.0% | 873,891 | 0.0% | 0.45% | -35.4% | |
| IMUX | IMMUNIC INC | $9,882,299 | -15.9% | 8,902,972 | 0.0% | 0.42% | +10.8% | |
| New | CORBUS PHARMACEUTICALS HLDGS | $9,755,900 | – | 215,600 | +100.0% | 0.42% | – | |
| CLXPF | CYBIN INC | $9,453,564 | -34.5% | 34,884,000 | 0.0% | 0.40% | -13.5% | |
| SYROS PHARMACEUTICALS INC | $8,635,456 | -3.6% | 1,673,538 | 0.0% | 0.37% | +27.0% | ||
| COGT | Buy | COGENT BIOSCIENCES INC | $8,435,952 | +181.7% | 1,000,706 | +124.5% | 0.36% | +269.1% |
| IMCR | Sell | IMMUNOCORE HLDGS PLCads | $6,778,000 | -63.6% | 200,000 | -30.2% | 0.29% | -52.0% |
| New | TYRA BIOSCIENCES INC | $5,964,270 | – | 373,000 | +100.0% | 0.25% | – | |
| New | SPYRE THERAPEUTICS INC | $4,584,450 | – | 195,000 | +100.0% | 0.20% | – | |
| PATH | New | UIPATH INCcl a | $4,590,160 | – | 362,000 | +100.0% | 0.20% | – |
| IMTX | New | IMMATICS N.V | $4,567,822 | – | 393,100 | +100.0% | 0.19% | – |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $4,432,380 | -21.3% | 93,000 | -28.5% | 0.19% | +3.3% |
| ABIO | New | ARCA BIOPHARMA INC | $3,830,000 | – | 1,000,000 | +100.0% | 0.16% | – |
| NTLA | New | INTELLIA THERAPEUTICS INC | $3,804,600 | – | 170,000 | +100.0% | 0.16% | – |
| EDIT | New | EDITAS MEDICINE INC | $3,810,720 | – | 816,000 | +100.0% | 0.16% | – |
| COLL | Sell | COLLEGIUM PHARMACEUTICAL INC | $3,767,400 | -73.1% | 117,000 | -67.6% | 0.16% | -64.6% |
| Sell | PRIME MEDICINE INC | $3,567,160 | -74.4% | 694,000 | -65.1% | 0.15% | -66.1% | |
| ACIU | Sell | AC IMMUNE SA | $3,291,750 | -75.1% | 825,000 | -81.5% | 0.14% | -67.2% |
| KZR | KEZAR LIFE SCIENCES INC | $3,015,600 | -33.5% | 5,026,000 | 0.0% | 0.13% | -12.3% | |
| SCYX | SCYNEXIS INC | $2,897,456 | +36.1% | 1,448,728 | 0.0% | 0.12% | +78.3% | |
| KPTI | Sell | KARYOPHARM THERAPEUTICS INC | $1,751,251 | -86.0% | 2,018,500 | -75.7% | 0.07% | -81.7% |
| WVE | New | WAVE LIFE SCIENCES LTD | $1,746,500 | – | 350,000 | +100.0% | 0.07% | – |
| HYPERFINE INC | $1,009,951 | -15.0% | 1,188,178 | 0.0% | 0.04% | +13.2% | ||
| CAREMAX INCcl a new | $59,148 | -42.1% | 21,200 | 0.0% | 0.00% | 0.0% | ||
| NUVBWS | Sell | NUVATION BIO INC*w exp 07/07/202 | $1,942 | -92.8% | 12,136 | -86.4% | 0.00% | -100.0% |
| KOD | Exit | KODIAK SCIENCES INC | $0 | – | -300,000 | -100.0% | -0.05% | – |
| PACB | Exit | PACIFIC BIOSCIENCES CALIF IN | $0 | – | -675,000 | -100.0% | -0.08% | – |
| XFOR | Exit | X4 PHARMACEUTICALS INC | $0 | – | -2,413,000 | -100.0% | -0.11% | – |
| Exit | GINKGO BIOWORKS HOLDINGS INC | $0 | – | -3,000,000 | -100.0% | -0.11% | – | |
| Exit | AN2 THERAPEUTICS INC | $0 | – | -1,150,000 | -100.0% | -0.12% | – | |
| EBS | Exit | EMERGENT BIOSOLUTIONS INC | $0 | – | -1,908,000 | -100.0% | -0.16% | – |
| Exit | KYVERNA THERAPEUTICS INC | $0 | – | -202,333 | -100.0% | -0.16% | – | |
| IPSC | Exit | CENTURY THERAPEUTICS INC | $0 | – | -1,221,555 | -100.0% | -0.16% | – |
| Exit | STRUCTURE THERAPEUTICS INCcall | $0 | – | -150,000 | -100.0% | -0.21% | – | |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -588,500 | -100.0% | -0.35% | – |
| RDNT | Exit | RADNET INC | $0 | – | -238,000 | -100.0% | -0.37% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -166,000 | -100.0% | -0.38% | – |
| Exit | ASTRIA THERAPEUTICS INC | $0 | – | -982,000 | -100.0% | -0.45% | – | |
| VERA | Exit | VERA THERAPEUTICS INCcl a | $0 | – | -383,500 | -100.0% | -0.53% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -33,300 | -100.0% | -0.58% | – |
| Exit | CARIBOU BIOSCIENCES INC | $0 | – | -5,785,352 | -100.0% | -0.96% | – | |
| CYTK | Exit | CYTOKINETICS INCcall | $0 | – | -600,000 | -100.0% | -1.36% | – |
| CVS | Exit | CVS HEALTH CORP | $0 | – | -545,000 | -100.0% | -1.40% | – |
| ALPN | Exit | ALPINE IMMUNE SCIENCES INC | $0 | – | -1,174,700 | -100.0% | -1.50% | – |
| LLY | Exit | ELI LILLY & CO | $0 | – | -70,000 | -100.0% | -1.76% | – |
| ALGN | Exit | ALIGN TECHNOLOGY INC | $0 | – | -189,000 | -100.0% | -2.00% | – |
| FUSN | Exit | FUSION PHARMACEUTICALS INC | $0 | – | -6,500,328 | -100.0% | -4.47% | – |
| ITCI | Exit | INTRA-CELLULAR THERAPIES INCcall | $0 | – | -600,000 | -100.0% | -7.72% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC | 18 | Q2 2024 | 4.6% |
| ARVINAS INC | 17 | Q2 2024 | 4.9% |
| SYNDAX PHARMACEUTICALS INC | 17 | Q2 2024 | 3.2% |
| NATERA INC | 16 | Q2 2024 | 3.5% |
| IDEAYA BIOSCIENCES INC | 16 | Q2 2024 | 2.5% |
| ABBVIE INC | 15 | Q2 2024 | 9.7% |
| AVANTOR INC | 14 | Q2 2024 | 6.0% |
| ZENTALIS PHARMACEUTICALS INC | 14 | Q3 2023 | 4.8% |
| IMMUNOCORE HLDGS PLC | 14 | Q2 2024 | 2.0% |
| ALPINE IMMUNE SCIENCES INC | 14 | Q1 2024 | 1.5% |
View Avidity Partners Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Context Therapeutics Inc. | May 13, 2024 | 7,500,431 | 9.9% |
| ARCA biopharma, Inc. | April 09, 2024 | 1,000,000 | 6.9% |
| Jasper Therapeutics, Inc. | March 27, 2024 | 760,000 | 5.1% |
| Altimmune, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
| IDEAYA Biosciences, Inc. | February 14, 2024 | 1,520,000 | 2.4% |
| Karyopharm Therapeutics Inc. | February 14, 2024 | 11,188,743 | 9.5% |
| Kezar Life Sciences, Inc. | February 14, 2024 | 5,025,454 | 6.9% |
| Akero Therapeutics, Inc. | February 13, 2024 | 235,000 | 0.4% |
| ARVINAS, INC. | February 13, 2024 | 2,985,117 | 4.4% |
| Cyteir Therapeutics, Inc.Sold out | February 13, 2024 | 0 | 0.0% |
View Avidity Partners Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| SC 13G | 2024-05-13 |
| SC 13G | 2024-04-09 |
| SC 13G | 2024-03-27 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Avidity Partners Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.